Zhongyuan Union Cell & Gene Engineering (SHSE:600645) Beneish M-Score: -2.62 (As of Jul. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600645 Zhongyuan Union Cell & Gene Engineering Corp Ltd SHSE:600645
60 GF Score
Price ¥17.92
GF Value ¥20.36
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Zhongyuan Union Cell & Gene Engineering Beneish M-Score?

Zhongyuan Union Cell & Gene Engineering SHSE:600645 -6.18% 60 Beneish M-Score is -2.62 as of Jul. 17, 2026. GuruFocus rates SHSE:600645 with a GF Score™ of 60/100 and a GF Value™ of ¥20.36 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 824 Biotechnology companies, Zhongyuan Union Cell & Gene Engineering ranks better than 61.17% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.62 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Zhongyuan Union Cell & Gene Engineering's Beneish M-Score or its related term are showing as below:

SHSE:600645' s Beneish M-Score Range Over the Past 10 Years
Min: -3.65   Med: -2.58   Max: -1.27
Current: -2.62

During the past 13 years, the highest Beneish M-Score of Zhongyuan Union Cell & Gene Engineering was -1.27. The lowest was -3.65. And the median was -2.58.


Zhongyuan Union Cell & Gene Engineering Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Zhongyuan Union Cell & Gene Engineering's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhongyuan Union Cell & Gene Engineering Beneish M-Score Chart

Zhongyuan Union Cell & Gene Engineering Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.65 -2.43 -2.60 -2.65 -2.61

Zhongyuan Union Cell & Gene Engineering Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.74 -2.80 -2.83 -2.61 -2.62

SHSE:600645 vs VRTX, REGN, ALNY: Beneish M-Score Comparison

For the Biotechnology subindustry, Zhongyuan Union Cell & Gene Engineering's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhongyuan Union Cell & Gene Engineering Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhongyuan Union Cell & Gene Engineering's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Zhongyuan Union Cell & Gene Engineering's Beneish M-Score falls into.


SHSE:600645
60GF Score
Zhongyuan Union Cell & Gene Engineering Corp Ltd SHSE:600645
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhongyuan Union Cell & Gene Engineering Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Zhongyuan Union Cell & Gene Engineering for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0497+0.528 * 0.9846+0.404 * 0.953+0.892 * 0.9241+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.6407+4.679 * -0.035201-0.327 * 0.9537
=-2.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ¥602 Mil.
Revenue was 317.341 + 362.488 + 376.09 + 365.58 = ¥1,421 Mil.
Gross Profit was 220.77 + 259.965 + 264.059 + 252.481 = ¥997 Mil.
Total Current Assets was ¥2,662 Mil.
Total Assets was ¥5,265 Mil.
Property, Plant and Equipment(Net PPE) was ¥604 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥357 Mil.
Total Current Liabilities was ¥1,413 Mil.
Long-Term Debt & Capital Lease Obligation was ¥53 Mil.
Net Income was 24.245 + 5.924 + 50.136 + 29.74 = ¥110 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0 Mil.
Cash Flow from Operations was 28.146 + 90.772 + 99.824 + 76.638 = ¥295 Mil.
Total Receivables was ¥621 Mil.
Revenue was 350.79 + 379.521 + 403.617 + 404.304 = ¥1,538 Mil.
Gross Profit was 239.644 + 255.719 + 287.903 + 279.266 = ¥1,063 Mil.
Total Current Assets was ¥2,488 Mil.
Total Assets was ¥5,249 Mil.
Property, Plant and Equipment(Net PPE) was ¥669 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥604 Mil.
Total Current Liabilities was ¥1,467 Mil.
Long-Term Debt & Capital Lease Obligation was ¥66 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(602.031 / 1421.499) / (620.629 / 1538.232)
=0.423518 / 0.403469
=1.0497

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1062.532 / 1538.232) / (997.275 / 1421.499)
=0.690749 / 0.701566
=0.9846

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2661.762 + 603.521) / 5265.07) / (1 - (2488.024 + 668.931) / 5248.825)
=0.379822 / 0.398541
=0.953

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1421.499 / 1538.232
=0.9241

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 668.931)) / (0 / (0 + 603.521))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(357.457 / 1421.499) / (603.778 / 1538.232)
=0.251465 / 0.392514
=0.6407

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((52.835 + 1413.29) / 5265.07) / ((65.665 + 1466.847) / 5248.825)
=0.278463 / 0.291972
=0.9537

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(110.045 - 0 - 295.38) / 5265.07
=-0.035201

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Zhongyuan Union Cell & Gene Engineering has a M-score of -2.62 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.62 mean?
Zhongyuan Union Cell & Gene Engineering (SHSE:600645) has a Beneish M-Score of -2.62 as of Jul. 17, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Zhongyuan Union Cell & Gene Engineering and its competitors. According to the industry distribution chart, Zhongyuan Union Cell & Gene Engineering ranks #320 out of 824 companies in the Biotechnology industry, placing it in the top 38.8%.
Is Zhongyuan Union Cell & Gene Engineering's Beneish M-Score too high?
Zhongyuan Union Cell & Gene Engineering's current Beneish M-Score is -2.62. Based on the distribution chart, Zhongyuan Union Cell & Gene Engineering ranks #320 out of 824 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Zhongyuan Union Cell & Gene Engineering has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhongyuan Union Cell & Gene Engineering's Beneish M-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Zhongyuan Union Cell & Gene Engineering ranks #320 out of 824 companies for Beneish M-Score. This puts Zhongyuan Union Cell & Gene Engineering in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Zhongyuan Union Cell & Gene Engineering and its competitors. Zhongyuan Union Cell & Gene Engineering's current Beneish M-Score is -2.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhongyuan Union Cell & Gene Engineering stock overvalued right now?
Based on GuruFocus' analysis, Zhongyuan Union Cell & Gene Engineering (SHSE:600645) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥20.36, compared to a current price of ¥17.92 — trading 12% below its estimated fair value. The current Beneish M-Score is -2.62. Zhongyuan Union Cell & Gene Engineering's overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Zhongyuan Union Cell & Gene Engineering (SHSE:600645), the current Beneish M-Score is -2.62 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhongyuan Union Cell & Gene Engineering (SHSE:600645) Overvalued in 2026?

Based on GuruFocus' analysis, Zhongyuan Union Cell & Gene Engineering stock appears to be undervalued. The current stock price of ¥17.92 is trading 12% below its estimated GF Value™ of ¥20.36. GuruFocus considers Zhongyuan Union Cell & Gene Engineering to be Modestly Undervalued.

Key valuation signals for SHSE:600645:

  • Beneish M-Score: -2.62
  • GF Value™: ¥20.36 vs. price of ¥17.92 (12% below fair value)
  • GF Score™: 60/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600645 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhongyuan Union Cell & Gene Engineering Business Description

Address 45 East of Tianjin Airport Economic Zone nine, Tianjin, CHN, 300304
Zhongyuan Union Cell & Gene Engineering Corp Ltd is engaged in stem cell technology research, as well as detection and storage sources of stem cells in China. The company insists on the core strategy upon dual-core development of 'cell + gene' with the major businesses covering various cell storage businesses of newborns and adults; the preparation and storage of cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, adipose-derived stem cells and immune cells; genetic testing services relating to children's genes.
60GF Score

Get the complete analysis for SHSE:600645

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥17.92
Price
¥20.36
GF Value